Funded Grants

PI Namesort descending Organization Title Project Number Major Program / Research Group Funding Opportunity Announcement
Crew, Katherine D Columbia University Health Sciences Multicenter trial of decision support for breast cancer chemoprevention 5R01CA226060-02 Breast and Gynecologic Cancer PAR-18-559
Curiel-Lewandrowski, Clara University Of Arizona Targeted Prevention for Non-Melanoma Skin Cancer 3P01CA229112-02S1 Chemopreventive Agent Development PA-18-906
Dabelea, Dana University Of Colorado Denver 06/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project 5U01DK048375-27 Breast and Gynecologic Cancer, DPPOS Study RFA-DK-15-503
Dagogo-Jack, Samuel University Of Tennessee Health Sci Ctr 09/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project 5U01DK048411-27 Breast and Gynecologic Cancer, DPPOS Study RFA-DK-15-503
Dai, Qi Vanderbilt University Medical Center Methylomic biomarkers for magnesium deficiency and colon neoplasia prevention 5R01CA202936-05 Nutritional Science PAR-13-375
Dai, Qi Vanderbilt University Medical Center Translating gene-calcium interactions to precision medicine for colorectal cancer 5U01CA182364-06 Early Detection, Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial PAR-13-036
Damaj, M. Imad Virginia Commonwealth University Genetic basis of chemotherapy-induced neuropathy in a reduced complexity cross 5R01CA221260-03 Community Oncology and Prevention Trials, Supportive Care and Symptom Management, Pain PA-16-188
Dandoy, Christopher Eugene Cincinnati Childrens Hosp Med Ctr Automated Activities of Daily Living (ADL) Adherence System to Reduce Complications After Intensive Cancer Therapy in Pediatrics 5R21CA223503-02 Community Oncology and Prevention Trials, Supportive Care and Symptom Management, Pediatrics/Adolescents/Young Adult PAR-16-278
Dantzer, Robert University Of Tx Md Anderson Can Ctr The Metabolic Basis of Cancer-Related Fatigue 5R01CA193522-06 Community Oncology and Prevention Trials, Oral Complications PA-18-484
Darmani, Nissar A Western University Of Health Sciences Substance P tachykininergic NK1 receptor emetic signal transduction pathways 5R01CA207287-04 Community Oncology and Prevention Trials, Supportive Care and Symptom Management, Nausea PA-16-160
Dashwood, Roderick H Texas A&M University Health Science Ctr CCAR2 as a Target for Prevention of Colorectal Cancer. 5R01CA122959-08 Nutritional Science PA-16-160
Davis, Terisa UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR Targeting P2X7 Receptor Antagonists for Prevention of Pancreatic Cancer 261201200013I-0-26100004-1 PREVENT Cancer Preclinical Drug Development Program
Davis, Terisa UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR Development of Muc1 Vaccine for the Prevention of Pancreatic Cancer 261201200013I-0-26100005-1 PREVENT Cancer Preclinical Drug Development Program
Davis, Terisa Ohio State University NSAID Chemoprevention in Colorectal Cancer 261201200020I-0-26100005-1 PREVENT Cancer Preclinical Drug Development Program
Davis, Terisa University of Alabama Evaluation of GLG-302, a STAT3 Antagonist, in the Prevention of Mammary Cancer 261201200021I-0-26100004-1 PREVENT Cancer Preclinical Drug Development Program

Pages